00000nam 2200000za 4500 9.864389 CaOODSP 20221107161528 cr ||||||||||| 181107s2018 onc #o f000 0 eng d 9780660284279 CaOODSP eng n-cn--- H164-250/2018E-PDF Notifying Health Canada of foreign actions [electronic resource] : guidance document for industry. Ottawa : Health Canada, 2018. iii, 7 p. Issued also in French under title: Aviser Santé Canada des mesures prises dans les pays étrangers : document d’orientation à l’intention de l’industrie. Cover title. Issued also in HTML format. "The purpose of this guidance document is to provide manufacturers, importers and other holders of instruments of market authorization (Drug Identification Numbers (DIN) and Notices of Compliance (NOC)) under the Food and Drug Regulations, with information that may be useful in achieving compliance with the regulatory requirements of notification to Health Canada of foreign regulatory actions as outlined in sections C.01.050 (2)(a), (b) and (c) and C.01.050 (3) of the Food and Drug Regulations"--Introduction, p. 1. gccst Regulations gccst Health care products Canada. Health Canada. Aviser Santé Canada des mesures prises dans les pays étrangers (CaOODSP)9.864391 PDF 364 KB https://publications.gc.ca/collections/collection_2019/sc-hc/H164-250-2018-eng.pdf HTML N/A https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/foreign-actions-profile/guidance-document.html Pub.: 180564